
Caprolactam Chemicals Ltd: Valuation Shifts Signal Changing Price Attractiveness
2026-04-15 08:00:44Caprolactam Chemicals Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating despite its sky-high price-to-earnings (P/E) ratio. This transition reflects a complex interplay of market sentiment, financial metrics, and sector comparisons, raising important considerations for investors navigating the commodity chemicals space.
Read More
Caprolactam Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-04-06 08:00:23Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. Despite a challenging market environment reflected in its recent share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a potential re-rating opportunity relative to its historical and peer benchmarks.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSENewspaper Advertisement of the Audited Financial Result for Quarter ended 31 March 2026
Board Meeting Intimation for Prior Intimation Of Board Meeting To Consider Audited Financial Results For Quarter And Financial Year Ended March 31 2026
06-May-2026 | Source : BSECaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Prior Intimation of Board Meeting to consider Audited Financial Results for quarter and financial year ended March 31 2026
Non Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations 2015
22-Apr-2026 | Source : BSENon Applicability of Regulation 23(9) of SEBI (LODR) Regulations 2015
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available